Prudent Man Advisors LLC Acquires 2,211 Shares of SPDR S&P Biotech ETF $XBI

Prudent Man Advisors LLC raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 18.7% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,028 shares of the exchange traded fund’s stock after purchasing an additional 2,211 shares during the period. Prudent Man Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,163,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in XBI. JPMorgan Chase & Co. lifted its holdings in shares of SPDR S&P Biotech ETF by 625.1% during the 1st quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after acquiring an additional 12,344,558 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 33.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after acquiring an additional 3,353,029 shares during the period. Simplex Trading LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 116.1% during the 1st quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock worth $19,548,000 after acquiring an additional 1,741,445 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $85,155,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $48,660,000.

SPDR S&P Biotech ETF Trading Up 0.8%

Shares of SPDR S&P Biotech ETF stock opened at $108.39 on Friday. The company has a 50 day moving average of $98.08 and a 200-day moving average of $87.88. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $110.96. The company has a market cap of $6.65 billion, a PE ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.